Evolent Health (EVH) PT Raised to $9.50 at Goldman Sachs
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.51 -3.63%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Goldman Sachs analyst Robert Jones raised the price target on Evolent Health (NYSE: EVH) to $9.50 (from $8.50) while maintaining a Neutral rating.
You May Also Be Interested In
- Evolent Health (EVH) PT Raised to $6 at TD Cowen
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
- Alkem Laboratories Ltd (ALKEM:IN) PT Lowered to INR6,850 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
